Bressi Edoardo, Sedláček Kamil, Čurila Karol, Cano Óscar, Luermans Justin G L M, Rijks Jesse H J, Meiburg Roel, Smits Karin C, Nguyen Uyen Chau, De Ruvo Ermenegildo, Calò Leonardo, Kron Jordana, Ellenbogen Kenneth A, Prinzen Frits, Vernooy Kevin, Grieco Domenico
Department of Cardiovascular Sciences, Policlinico Casilino of Rome, Via Casilina, 1049, 00169, Rome, Italy.
Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, The Netherlands.
J Interv Card Electrophysiol. 2024 Dec;67(9):2039-2050. doi: 10.1007/s10840-024-01863-2. Epub 2024 Jul 6.
The clinical impact of Periprocedural myocardial injury (PMI) in patients undergoing permanent pacemaker implantation with Left Bundle Branch Area Pacing (LBBAP) is unknown.
130 patients undergoing LBBAP from January 2020 to June 2021 and completing 12 months follow up were enrolled to assess the impact of PMI on composite clinical outcome (CCO) defined as any of the following: all-cause death, hospitalization for heart failure (HHF), hospitalization for acute coronary syndrome (ACS) and ventricular arrhythmias (VAs). High sensitivity Troponin T (HsTnT) was measured up to 24-h after intervention to identify the peak HsTnT values. PMI was defined as increased peak HsTnT values at least > 99th percentile of the upper reference limit (URL: 15 pg/ml) in patients with normal baseline values.
PMI occurred in 72 of 130 patients (55%). ROC analysis yielded a post-procedural peak HsTnT cutoff of fourfold the URL for predicting the CCO (AUC: 0.692; p = 0.023; sensitivity 73% and specificity 71%). Of the enrolled patients, 20% (n = 26) had peak HsTnT > fourfold the URL. Patients with peak HsTnT > fourfold the URL exhibited a higher incidence of the CCO than patients with peak HsTnT ≤ fourfold the URL (31% vs. 10%; p = 0.005), driven by more frequent hospitalizations for ACS (15% vs. 3%; p = 0.010). Multiple (> 2) lead repositions attempts, the use of septography and stylet-driven leads were independent predictors of higher risk of PMI with peak HsTnT > fourfold the URL.
PMI seems common among patients undergoing LBBAP and may be associated with an increased risk of clinical outcomes in case of more pronounced (peak HsTnT > fourfold the URL) myocardial damage occurring during the procedure.
围手术期心肌损伤(PMI)对接受左束支区域起搏(LBBAP)的永久性起搏器植入患者的临床影响尚不清楚。
纳入2020年1月至2021年6月期间接受LBBAP并完成12个月随访的130例患者,以评估PMI对复合临床结局(CCO)的影响,CCO定义为以下任何一种情况:全因死亡、因心力衰竭住院(HHF)、因急性冠状动脉综合征住院(ACS)和室性心律失常(VA)。在干预后24小时内测量高敏肌钙蛋白T(HsTnT),以确定HsTnT峰值。PMI定义为基线值正常的患者中,HsTnT峰值至少高于参考上限(URL:15 pg/ml)的第99百分位数。
130例患者中有72例(55%)发生PMI。ROC分析得出,术后HsTnT峰值截断值为URL的四倍时可预测CCO(AUC:0.692;p = 0.023;敏感性73%,特异性71%)。在纳入的患者中,20%(n = 26)的HsTnT峰值>URL的四倍。HsTnT峰值>URL四倍的患者CCO发生率高于HsTnT峰值≤URL四倍的患者(31%对10%;p = 0.005),这主要是由于ACS住院更频繁(15%对3%;p = 0.010)。多次(>2次)导线重新定位尝试、使用造影剂和探条驱动导线是PMI风险较高且HsTnT峰值>URL四倍的独立预测因素。
PMI在接受LBBAP的患者中似乎很常见,如果在手术过程中发生更明显的(HsTnT峰值>URL四倍)心肌损伤,可能与临床结局风险增加有关。